<< KidneyTel system helps manage health issues faced by kidney patients | New uninsured number: Up to 46.3 million in mid-2008 >>
Read in | English | EspaƱol | Português | Dansk | Svenska

ABTA launches new research program on brain tumor therapy

Published on September 11, 2009 at 2:09 AM · No Comments

The American Brain Tumor Association has launched a new Special Projects Discovery Grant program to support fresh and creative research ideas for solving the challenges of brain tumor diagnosis and treatment.

"While there have been some significant scientific breakthroughs over the past decade resulting in better treatments and longer lives for many patients, a brain tumor remains a devastating diagnosis," said American Brain Tumor Association Executive Director Elizabeth Wilson

"Through this program, we hope to stimulate and invigorate greater engagement in brain tumor research across and beyond traditional medical and scientific research disciplines and specialties and bring new perspectives, ideas and dreams to the foreground," said Wilson.

Each year, approximately 60,000 Americans are diagnosed with a primary brain tumor and more than 150,000 have cancer that spreads to, or "metastasizes," to the brain.

The American Brain Tumor Association Special Project Discovery Grant pilot program - one of four grant programs offered through ABTA's Research Awards Program - will offer one-year, $50,000 grants for high-risk, high-impact projects deemed to have the potential to change current diagnostic or treatment paradigms for adult and/or pediatric brain tumors.

Investigators from sciences outside traditional biology fields are encouraged to apply. Proposed studies should be at the hypothesis-driven level. Priority will be given to proposals that address underfunded areas of brain tumor research. Of particular interest for this first round of funding are proposals pertaining to meningioma or oligodendroglioma, however, other research topics are also invited.

Eligible researchers include advanced post-doctoral trainees, junior faculty, and principal investigators who have not received funding at the equivalent of NIH RO1, or higher level.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading